References:

1. Aran A, Einen M, Lin L, Plazzi G, Nishino S, Mignot E. Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: a retrospective study of 51 children. Sleep. 2010;33(11):1457-1464.
2. Ito E, Inoue Y. [The International Classification of Sleep Disorders, third edition. American Academy of Sleep Medicine. Includes bibliographies and index]. Nihon rinsho Japanese journal of clinical medicine. 2015;73(6):916-923.
3. M. T. International Classification of Sleep Disorders. Sleep Disorders Medicine 2017.
4. Kornum BR, Jennum P. The case for narcolepsy as an autoimmune disease. Expert review of clinical immunology.2020;16(3):231-233.
5. Scammell TE. The neurobiology, diagnosis, and treatment of narcolepsy. Annals of neurology. 2003;53(2):154-166.
6. Mahlios J, De la Herran-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol. 2013;23(5):767-773.
7. Carlander B, Eliaou JF, Billiard M. Autoimmune hypothesis in narcolepsy. Neurophysiol Clin. 1993;23(1):15-22.
8. Bonvalet M, Ollila HM, Ambati A, Mignot E. Autoimmunity in narcolepsy. Current opinion in pulmonary medicine.2017;23(6):522.
9. Mignot E, Thorsby E. Narcolepsy and the HLA system. N Engl J Med. 2001;344(9):692.
10. Ellul MA, Benjamin L, Singh B, et al. Neurological associations of COVID-19. The Lancet Neurology. 2020;19(9):767-783.
11. Singh AK, Mahlios J, Mignot E. Genetic association, seasonal infections and autoimmune basis of narcolepsy. J Autoimmun.2013;43:26-31.
12. Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in China. Annals of neurology. 2011;70(3):410-417.
13. Fernandez FX, Flygare J, Grandner MA. Narcolepsy and COVID-19: sleeping on an opportunity? J Clin Sleep Med. 2020;16(8):1415.
14. Ruoff C, Pizza F, Trotti LM, et al. The MSLT is Repeatable in Narcolepsy Type 1 But Not Narcolepsy Type 2: A Retrospective Patient Study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine.2018;14(1):65-74.
15. Frauscher B, Ehrmann L, Mitterling T, et al. Delayed diagnosis, range of severity, and multiple sleep comorbidities: a clinical and polysomnographic analysis of 100 patients of the innsbruck narcolepsy cohort. J Clin Sleep Med. 2013;9(8):805-812.
16. Medicine AAoS. International classification of sleep disorders.Diagnostic and coding manual. 2005:51-55.
17. Lopez R, Doukkali A, Barateau L, et al. Test-Retest Reliability of the Multiple Sleep Latency Test in Central Disorders of Hypersomnolence.Sleep. 2017;40(12).
18. Bassetti CLA, Kallweit U, Vignatelli L, et al. European guideline and expert statements on the management of narcolepsy in adults and children. European Journal of Neurology. 2021;28(9):2815-2830.
19. Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep.2009;32(8):979-983.
20. Natarajan N, Jain SV, Chaudhry H, Hallinan BE, Simakajornboon N. Narcolepsy-cataplexy: is streptococcal infection a trigger? J Clin Sleep Med. 2013;9(3):269-270.
21. Kornum BR, Faraco J, Mignot E. Narcolepsy with hypocretin/orexin deficiency, infections and autoimmunity of the brain. Curr Opin Neurobiol. 2011;21(6):897-903.
22. Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain : a journal of neurology. 2013;136(Pt 8):2486-2496.
23. Haggmark-Manberg A, Zandian A, Forsstrom B, et al. Autoantibody targets in vaccine-associated narcolepsy. Autoimmunity.2016;49(6):421-433.
24. Partinen M, Kornum BR, Plazzi G, Jennum P, Julkunen I, Vaarala O. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. The Lancet Neurology. 2014;13(6):600-613.
25. Choe YJ, Bae GR, Lee DH. No association between influenza A(H1N1)pdm09 vaccination and narcolepsy in South Korea: an ecological study. Vaccine. 2012;30(52):7439-7442.
26. Dodd CN, de Ridder M, Huang WT, et al. Incidence rates of narcolepsy diagnoses in Taiwan, Canada, and Europe: The use of statistical simulation to evaluate methods for the rapid assessment of potential safety issues on a population level in the SOMNIA study. PloS one. 2018;13(10):e0204799.
27. Wallenius M, Lind A, Akel O, et al. Autoantibodies in Pandemrix®-induced narcolepsy: Nine candidate autoantigens fail the conformational autoantibody test. Autoimmunity.2019;52(4):185-191.
28. Jackson MW, Reed JH, Smith AJ, Gordon TP. An autoantibody in narcolepsy disrupts colonic migrating motor complexes. J Neurosci. 2008;28(49):13303-13309.
29. Häggmark-Månberg A, Zandian A, Forsström B, et al. Autoantibody targets in vaccine-associated narcolepsy. Autoimmunity.2016;49(6):421-433.
30. Tanaka S, > Honda Y, Inoue Y, Honda M. Detection of autoantibodies against hypocretin, hcrtr1, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Sleep.2006;29(5):633-638.
31. Smith AJ, Jackson MW, Neufing P, McEvoy RD, Gordon TP. A functional autoantibody in narcolepsy. Lancet. 2004;364(9451):2122-2124.
32. Katzav A, Arango MT, Kivity S, et al. Passive transfer of narcolepsy: anti-TRIB2 autoantibody positive patient IgG causes hypothalamic orexin neuron loss and sleep attacks in mice. J Autoimmun. 2013;45:24-30.
33. Orjatsalo M, Partinen E, Wallukat G, Alakuijala A, Partinen M. Activating autoantibodies against G protein-coupled receptors in narcolepsy type 1. Sleep Med. 2021;77:82-87.
34. Ramberger M, Hogl B, Stefani A, Mitterling T, Reindl M, Lutterotti A. CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1. Sleep. 2017;40(3):zsw070.
35. Schirinzi T, Landi D, Liguori C. COVID-19: dealing with a potential risk factor for chronic neurological disorders. Journal of neurology. 2021;268(4):1171-1178.
36. Awogbindin IO, Ben-Azu B, Olusola BA, et al. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease.Frontiers in Cellular Neuroscience. 2021;15:199.
37. Warren RL, Birol I. HLA alleles measured from COVID-19 patient transcriptomes reveal associations with disease prognosis in a New York cohort. PeerJ. 2021;9:e12368.
38. Mignot E, Black S. Narcolepsy risk and COVID-19. J Clin Sleep Med. 2020;16(10):1831-1833.
39. de Martin Truzzi G, Naufel MF, Tufik S, Coelho FM. The influence of narcolepsy on olfactory function: a review. Sleep Med.2020;72:75-81.
Table 1 The patient’s polysomnographic findings